Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
57 Cards in this Set
- Front
- Back
bipolar
|
imbalance of neurotransmitters
|
|
manic episode
|
elevation in norepi
|
|
depression
|
dec norepi
|
|
dysregulation of GABA
|
deficiency in GABA -> mania due to unopposed excitatory neurotransmitters
|
|
GABA
|
inhibitory neurotransmitter
|
|
unopposed excitatory neurotransmitter
|
dopamine
norepi |
|
Ca conc in CSF
|
effect the exitability of neurons
factor in depression to mania |
|
G proteins
|
signal transduction and activation of 2nd messenger sys for var neurotransmitters
|
|
hyperactive G proteins
|
mood instability
|
|
G proteins + glutamate
|
long term potentiation and cycling of mood disorders
|
|
inhibit G protein linked mechanism
|
Lithium
|
|
sx of mania
|
grandiose ideations
expansive self esteem pressured speech racing thoughts flight of ideas distratability psychomotor agitation engaging in dangerous and high risk activities |
|
mixed episode
|
coexistence of manic and depressive sx for at least 1 week
|
|
mood incongruent
|
asa mixed episode
|
|
bipolar 1 disorder
|
at least 1 manic or mood episode
|
|
bipolar 2 disorder
|
never exp a manic episode
exp 1 or more depressive episodes exp 1 hypomanic episode |
|
cyclothymia
|
depressive and hypomanic sx persist for 2 yrs
|
|
rapid cycling
|
dx when pt has exp at lest 4 depressive,manic,hypomanic or mixed episoded w/in 12 mo period
|
|
primary agts in trmt of bipolar
|
lithium
anticonvulsants |
|
mood stabilizers
|
anticonvulsants
|
|
olanzapine
|
only atypical antipsyc for trmt of acute mania
|
|
alternative to olanzapine
|
risperidone
quetapine ziprasidone |
|
first line agts bipolar trmt
|
lithium
lamotrigine |
|
1st line due to less risk for mania
|
bupropion
paroxetine |
|
lorazepam
|
short term mgmt of acute agitation assoc w/ mania
|
|
lithium indication
|
1st line therapy for trmt and prevention of bioilar except in mixed episodes or rapid cycling
|
|
lithium chemistry
|
monovalent cation
|
|
2 clinically relevant lithium salts
|
lithium carbonate
lithium citrate |
|
food
|
delay absorption but does not affect the extenet of absorption
|
|
distributes into total body water and penetrates many body tissues
|
lithium
|
|
lithium clearance directly proportional
|
GFR
|
|
not metabolized and its primarily eliminated thru kidneys
|
lithium
|
|
lithium moa
|
affect membrane stabilization
augment homeostasis by enhancing the fxn of 2ndary messenger sys |
|
secondary messenger sys
|
cyclic adenosine monophosphate
cyclic guanosine monophosphate phosphatidylinositol |
|
inhibit norepi release and accelerate its metabolism
|
lithium
|
|
dec rec sensitivity and inc presynaptic reuptake of norepi and 5HT
|
lithium
|
|
lithium therapeutic range
|
0.5 - 1.5 mEq/L
|
|
valproic acid - vpa
|
anticonvulsant
|
|
vpa indication
|
acute mania
mixed mania rapid cycling |
|
vpa moa
|
related to gaba modulation and 2nd messenger sys
|
|
vpa drug interaxn
|
cimetidine
chlorpromazine erythromycin delbamate salicylates |
|
dec vpa conc
|
rifampin
pehnobarb lamotrigine phenytoin cbz |
|
inc warfarin and zidovudine
|
vpa
|
|
lab test for vpa
|
cbc
liver fxn test |
|
cbz indication
|
anticonvulsant
|
|
cbz moa
|
modulate norepi and G protein bound linked 2nd messenger sys - cAMP
|
|
cbz se
|
induces enzymatic metabolism
|
|
monitor for cbz
|
serum conc
drug interaxn |
|
lab test for cbz
|
cbc
liver fxn test thyroid stimulating hormone electrolytes bun creatinine |
|
newer mood stabilizer
|
lamotrigine
gapapentin oxcarbazepine |
|
lamotrigine chemistry
|
similar to phenytoin and cbz
|
|
lamotrigine moa
|
blk Na mediated release of glutamate and aspartate at low conc
high con - blks gaba and acetylcholine release |
|
gabapentin adv eff
|
somnolence
nystagmus dizzy ataxia fatigue |
|
oxcarbazepine
|
alternative to cbz
|
|
leukocytosis
|
lithium
|
|
leukopenia
bld dyscrasia |
cbz and vpa
|
|
birth defects
|
lithium
vpa cbz |